Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.66 USD | -4.75% | -22.39% | -35.80% |
Jul. 03 | Barclays Downgrades Pacira BioSciences to Equalweight From Overweight, Adjusts Price Target to $25 From $38 | MT |
Jul. 02 | Pacira BioSciences Shares Tumble as FDA Approves Exparel Generic | DJ |
Official Publications
No official publication found
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Official Publications